Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 11,900 shares at $1.97 ($23K) on 2008-12-16, disclosed to the SEC on 2008-12-17.
Open-market purchase of $23k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.89 | 900 | $2K | 7.3% |
| 2 | $1.90 | 200 | $380 | 1.6% |
| 3 | $1.92 | 700 | $1K | 5.8% |
| 4 | $1.93 | 500 | $965 | 4.1% |
| 5 | $1.94 | 100 | $194 | 0.8% |
| 6 | $1.94 | 400 |
| $776 |
| 3.3% |
| 7 | $1.95 | 500 | $975 | 4.2% |
| 8 | $1.96 | 300 | $588 | 2.5% |
| 9 | $1.96 | 2,000 | $4K | 16.8% |
| 10 | $1.97 | 100 | $197 | 0.8% |
| 11 | $1.97 | 1,900 | $4K | 16.1% |
| 12 | $1.97 | 300 | $591 | 2.5% |
| 13 | $1.98 | 2,700 | $5K | 22.9% |
| 14 | $1.98 | 100 | $198 | 0.8% |
| 15 | $1.99 | 800 | $2K | 6.8% |
| 16 | $2.00 | 400 | $800 | 3.4% |
| Total | $1.96 avg | 11,900 | $23K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |